Adeptus Biotechnologies Corp. (ADPT) PT Raised to $60 at Morgan Stanley
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $43.44 +3.04%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 10 | New: 17
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 10 | New: 17
Trade Now!
Join SI Premium – FREE
Morgan Stanley analyst Tejas Savant raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $60.00 (from $46.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- UPDATE: UBS Upgrades EnLink Midstream, LLC (ENLC) to Buy
- Atos SE (ATOS:FP) (AEXAY) PT Lowered to EUR64 at Goldman Sachs
- Universal Forest Products (UFPI) PT Raised to $95 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
